The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome
#2: Consult with the Expert - Medical Management
Pre-Assessment

Before you view the tweetorial, please take this pre-assessment. Taking this pre-assessment does not immediately qualify learners to earn credit. Certificates of credit will only be sent to learners who also receive a passing score on the post-test (separate from this survey), and fill out the evaluation form and application for credit.

There is no fee to participate in this activity.

Question Title

* 1. Where are you in your career?

IBD Specialist

General GI/GI surgeon

Trainee/Fellow

APP

PharmD

Other (please specify)

Question Title

* 2. The GLP-2 analog teduglutide was shown in clinical studies to be associated with which of the following outcomes?

⬇️ Infection incidence

⬇️ Fluid requirement

⬆️ Caloric intake

⬇️ TPN complications

Question Title

* 3. A young adult patient with SBS is experiencing significant diarrhea (≥20 BM/day) despite tx with 8 mg/day loperamide. When the nurse discusses this with the doctor, a management strategy is formed, which includes which of the following?

⬆️ loperamide (12 mg/d)

⬇️ TPN daily volume

⬇️ # of days of TPN

⬆️ dietary fat

Question Title

* 4. A pediatric pt w/ SBS is being evaluated as an inpatient consult following a recent emergency resection, with 55 cm of small bowel remaining. Which of the following is an appropriate initial management strategy?

Altered diet & loperamide

NPO & PPIs

NPO & TPN

Antibiotics & codeine

Question Title

* 5. Which of the following is considered to be a potentially disease-modifying treatment for patients with SBS?

Clonidine

Loperamide

Somatropin

Teduglutide

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).
Please note that we will not forward or sell your contact information.

First and Last Name *

State/Province

ZIP/Postal Code *

Country

Email Address (required to receive credit) *

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome#2: Consult with the Expert - Medical Management ***Pre-Assessment***

Question Title

* 1. Where are you in your career?

Question Title

* 2. The GLP-2 analog teduglutide was shown in clinical studies to be associated with which of the following outcomes?

Question Title

* 3. A young adult patient with SBS is experiencing significant diarrhea (≥20 BM/day) despite tx with 8 mg/day loperamide. When the nurse discusses this with the doctor, a management strategy is formed, which includes which of the following?

Question Title

* 4. A pediatric pt w/ SBS is being evaluated as an inpatient consult following a recent emergency resection, with 55 cm of small bowel remaining. Which of the following is an appropriate initial management strategy?

Question Title

* 5. Which of the following is considered to be a potentially disease-modifying treatment for patients with SBS?

Question Title

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).*Please note that we will not forward or sell your contact information.*

The Long & Short of It: Optimizing Patient Care in Short Bowel Syndrome
#2: Consult with the Expert - Medical Management
Pre-Assessment

* 6. Please let us know who you are so we can connect your responses to your post-test & application to claim CME credit (completed after participating in the activity).
Please note that we will not forward or sell your contact information.